Intervention and Mechanisms of Alanyl‐glutamine for Inflammation, Nutrition, and Enteropathy
Open Access
- 8 July 2020
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 71 (3) , 393-400
Abstract
Objective: Determine the minimum dosage of alanyl‐glutamine (Ala‐Gln) required to improve gut integrity and growth in children at risk of environmental enteropathy (EE).Methods: This was a double‐blinded randomized placebo‐controlled dose‐response trial. We enrolled 140 children residing in a low‐income community in Fortaleza, Brazil. Participants were 2 to 60 months old and had weight‐for‐age (WAZ), height‐for‐age (HAZ), or weight‐for‐height (WHZ) z‐scores less than −1. We randomized children to 10 days of nutritional supplementation: Ala‐Gln at 3 g/day, Ala‐Gln at 6 g/day, Ala‐Gln at 12 g/day, or an isonitrogenous dose of glycine (Gly) placebo at 12.5 g/day. Our primary outcome was urinary lactulose‐mannitol excretion testing. Secondary outcomes were anthropometry, fecal markers of inflammation, urine metabolic profiles, and malabsorption (spot fecal energy).Results: Of 140 children, 103 completed 120 days of follow‐up (24% dropout). In the group receiving the highest dose of Ala‐Gln, we detected a modest improvement in urinary lactulose excretion from 0.19% on day 1 to 0.17% on day 10 (P = 0.05). We observed significant but transient improvements in WHZ at day 10 in 2 Ala‐Gln groups, and in WHZ and WAZ in all Ala‐Gln groups at day 30. We detected no effects on fecal inflammatory markers, diarrheal morbidity, or urine metabolic profiles; but did observe modest reductions in fecal energy and fecal lactoferrin in participants receiving Ala‐Gln.Conclusions: Intermediate dose Ala‐Gln promotes short‐term improvement in gut integrity and ponderal growth in children at risk of EE. Lower doses produced improvements in ponderal growth in the absence of enhanced gut integrity.Keywords
Funding Information
- National Science Foundation (OPP1066140)
This publication has 48 references indexed in Scilit:
- Arginine Consumption by the Intestinal Parasite Giardia intestinalis Reduces Proliferation of Intestinal Epithelial CellsPLOS ONE, 2012
- Alanyl-glutamine promotes intestinal epithelial cell homeostasis in vitro and in a murine model of weanling undernutritionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Preventing 5 million child deaths from diarrhea in the next 5 yearsNature Reviews Gastroenterology & Hepatology, 2011
- The Effect of Intravenous Alanyl-Glutamine Supplementation on Plasma Glutathione Levels in Intensive Care Unit Trauma Patients Receiving Enteral Nutrition: The Results of a Randomized Controlled TrialAnesthesia & Analgesia, 2009
- Glutamine Deprivation Alters Intestinal Tight Junctions via a PI3-K/Akt Mediated Pathway in Caco-2 CellsThe Journal of Nutrition, 2009
- Malnutrition as an enteric infectious disease with long-term effects on child developmentNutrition Reviews, 2008
- Wasting and Intestinal Barrier Function in Children Taking Alanyl‐Glutamine–Supplemented Enteral FormulaJournal of Pediatric Gastroenterology and Nutrition, 2007
- Diarrhea and Reduced Levels of Antiretroviral Drugs: Improvement with Glutamine or Alanyl-Glutamine in a Randomized Controlled Trial in Northeast BrazilClinical Infectious Diseases, 2004
- Lipid, nitrogen, water and energy content of a single stool sample in healthy children and children with cystic fibrosisEuropean Journal of Pediatrics, 2003
- Measurement of intestinal permeability using mannitol and lactulose in children with diarrheal diseasesBrazilian Journal of Medical and Biological Research, 1999